hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
about
Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cellsSmad proteins function as co-modulators for MEF2 transcriptional regulatory proteinsFunctional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C.Regulatory role of MEF2D in serum induction of the c-jun promoterBMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2CMultiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosisp38 and extracellular signal-regulated kinases regulate the myogenic program at multiple stepsDominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targetsActivated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiationD-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesisCombinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factorsPC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaBMutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2CAdvances in the genetic basis of coronary artery diseaseConnecting the speckles: Splicing kinases and their role in tumorigenesis and treatment responseMEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat modelInactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survivalFunctional and physical interactions between mammalian achaete-scute homolog 1 and myocyte enhancer factor 2AMEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cellsSodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogeninCooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) familyMEF2B is a potent transactivator expressed in early myogenic lineagesMyoD is indispensable for muscle-specific alternative splicing in mouse mitochondrial ATP synthase gamma-subunit pre-mRNAA conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cellsCalcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neuronsDifferentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cellsControl of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2Cp38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factorcDNA cloning and characterization of 5' upstream promoter region of porcine mef2c gene.A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5.MYOD mediates skeletal myogenic differentiation of human amniotic fluid stem cells and regeneration of muscle injury.Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb.Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization.Ca(2+)-dependent gene expression mediated by MEF2 transcription factors.RNA-binding protein Muscleblind-like 3 (MBNL3) disrupts myocyte enhancer factor 2 (Mef2) {beta}-exon splicing.Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
P2860
096bc64529b4f2b654b8fd675c5ebde3558341d21bd11cbcafb07905038c21ace4f0817452e991725f27e3e3855ac90c1009e65a57a9176d1360ef46927353a7ff752a23655814b12b8dec004f98b5d3ad39d140b31de06156df6efecb9e568531ddd47fe58b5c61cfa4f0f10be5785ccadc08013b57e916ec2f59e17fe077bad6d281164ffcdb92c42763f9f47f752c4706a639905a309ff3aab266a99c04f3
P248
Q22008552-6BAEFC4A-871D-414C-9FD0-9B3E438D7AC8Q24290752-3A03C3B3-BBC1-43DA-B311-D8953F432C57Q24296698-C3428269-9FA2-4FF0-A30E-27A269460ED4Q24297205-22790488-A4FE-49B2-8571-30AF4270C2B0Q24319672-EC03CE52-D57D-4E87-8656-2A75E80890CFQ24532869-565D1F37-F198-4994-85E8-A3A813AA6537Q24533544-CBEE8EF1-1125-44F6-9AE4-624515DF7BC0Q24534050-7A4DC9AD-D2B6-4AF4-A946-0CF99721C780Q24554203-EBDA510F-DD9B-486A-9538-C6FD4FF6A35BQ24554488-9A362115-044F-43D7-B7A8-4DC12C682B83Q24554516-DBF4FF06-66FC-4343-9B84-49DBEF9A6A9AQ24555638-F46E488F-E9F3-4D0B-A787-F2B2B272B7A5Q24562839-70E9AB20-3286-4379-9939-5705F6891443Q24594377-FD334BB2-FE47-4A28-9785-4127310456CDQ24626949-8060D2B5-964B-402D-99CF-D140B85F9C9DQ24649105-D895F1FE-4D60-4F95-B691-489592C854DAQ24682029-D8320150-30E6-439D-A6C9-AE67B8C21B01Q26824298-B16092A0-CFFB-4634-A927-D3C88DF856F6Q27322685-215AB59D-5FE5-4107-BB8F-3F15E7E7F335Q28191655-17771CA2-5770-4429-B4B9-EB974E3FF659Q28281878-A1165519-CFD9-4749-8BF1-898ABC5A29BAQ28289460-1E986709-1D2C-4174-82C8-2A3248BC6F2FQ28385528-715CB991-0F50-4A1A-8EB2-779EE84DD7FDQ28504632-29BBF092-74A5-4B2F-BAF5-21F018E2DD3CQ28505977-F238C2EF-28CF-4B96-8439-2945BA98C4B3Q28506896-942630B3-854B-45A9-A523-319C6A106600Q28571145-43FF99B4-B30B-4E03-A516-DE16B4DB79F7Q28583015-2CE22821-3855-425E-A6D3-20A0A6085688Q28586759-674BE201-4FC6-4F67-9EF9-9F151C7A8BC3Q28589290-AFD234BD-DEE6-46EE-90FE-69E7FFCFBE61Q28646220-0F812900-99A6-4B83-B057-92F2799CA273Q30397079-FC1FF1BC-1ABB-481C-B9E9-5089D86561D9Q33652314-35D5E668-6E83-4A00-9AD2-4C71B843C520Q33745860-24D2FFAD-D2DA-4D8C-9046-D42531341DB2Q33780318-D1AD8A70-8E6A-4813-9BAF-68DE318CF027Q33878919-5D5B465F-B312-4505-A715-40B1498268F8Q33885290-CC0F467C-995A-467A-B540-4841DC10ACB8Q34231994-448491ED-7D22-4C31-ACC7-460C28F68C3BQ34481343-86B038B9-A429-4485-9DFE-E1435E1B3CECQ34801443-F760BB95-2013-45A1-8A76-D134FF3A9A75
P2860
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@ast
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@en
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@en-gb
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@nl
type
label
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@ast
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@en
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@en-gb
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@nl
prefLabel
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@ast
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@en
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@en-gb
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@nl
P2093
P2860
P921
P356
P1476
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
@en
P2093
B Nadal-Ginard
J C McDermott
M C Cardoso
S A Lipton
P2860
P304
P356
10.1128/MCB.13.4.2564
P407
P577
1993-04-01T00:00:00Z